Apatinib Plus Temozolomide: An Effective Salvage Treatment for Recurrent Glioblastoma

Apatinib Plus Temozolomide: An Effective Salvage Treatment for Recurrent Glioblastoma

BackgroundTreatment for recurrent glioblastoma is poor, and there is a need for better therapies. Here we retrospectively assessed the efficacy and toxicity of temozolomide plus apatinib, an oral small-molecule tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor 2 in recu...

Full description

Bibliographic Details
Main Authors: Jingjing Ge, Cheng Li, Fengjun Xue, Shaopei Qi, Zhimeng Gao, Chunjiang Yu, Junping Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
glioblastoma
apatinib
angiogenesis inhibitors
temozolomide
VEGFR-2
chemotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.601175/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.601175/full

Similar Items